Velan Capital Investment Management LP Portfolio Holdings

Velan Capital Investment Management LP

  • $58 Million
  • Q1 2025

Velan Capital Investment Management LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $58 Million distributed in 49 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Heron Therapeutics, Inc. with a value of $15.4M, Spring Works Therapeutics, Inc. with a value of $8.19M, Protara Therapeutics, Inc. with a value of $7.1M, Verona Pharma PLC with a value of $6.03M, and Liquidia Corp with a value of $4.43M.

Examining the 13F form we can see an increase of $9.55M in the current position value, from $48.4M to 58M.

Velan Capital Investment Management LP is based out at Alpharetta, GA

Below you can find more details about Velan Capital Investment Management LP portfolio as well as his latest detailed transactions.

Portfolio value $58 Million
Healthcare: $58 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$217M
$15.4 Million 26.51% of portfolio
6,986,744
Q3 2023 Added 55.26%
$2.91B
$8.19 Million 14.12% of portfolio
185,520
Q4 2024 New
$35.6M
$7.1 Million 12.25% of portfolio
1,667,800
Q1 2025 Added 5.62%
$4.51B
$6.03 Million 10.4% of portfolio
95,000
Q1 2025 Added 90.0%
$926M
$4.43 Million 7.63% of portfolio
300,000
Q3 2024 New
$170M
$3.29 Million 5.67% of portfolio
665,000
Q1 2025 Added 121.67%
$20.7M
$2.43 Million 4.19% of portfolio
904,029
Q2 2023 New
$101M
$2.41 Million 4.16% of portfolio
917,668
Q1 2025 New
$416M
$1.78 Million 3.06% of portfolio
182,083
Q1 2025 Added 0.39%
$149M
$1.16 Million 2.0% of portfolio
400,000
Q1 2025 Reduced 50.0%
$43.3M
$1.1 Million 1.89% of portfolio
323,973
Q4 2024 New
$548M
$1.04 Million 1.8% of portfolio
655,000
Q1 2025 Added 1,236.73%
$104M
$1.03 Million 1.78% of portfolio
153,500
Q1 2025 New
$26.4M
$911,000 1.57% of portfolio
747,410
Q1 2025 New
$48M
$669,000 1.15% of portfolio
1,030,000
Q1 2025 Added 3,333.33%
$116M
$140,000 0.24% of portfolio
80,000
Q1 2025 Added 14.29%
$109M
$82,000 0.14% of portfolio
75,000
Q4 2024 New
$134M
$68,000 0.12% of portfolio
50,000
Q1 2025 New
$117M
$67,000 0.12% of portfolio
55,000
Q4 2024 New
$121M
$59,000 0.1% of portfolio
45,000
Q1 2025 Added 11.11%
$79.2M
$60,000 0.1% of portfolio
28,000
Q1 2025 Added 55.56%
$10.9M
$54,000 0.09% of portfolio
90,000
Q4 2024 Reduced 93.03%
$223M
$54,000 0.09% of portfolio
14,000
Q1 2025 New
$94M
$53,000 0.09% of portfolio
35,000
Q1 2025 Added 29.63%
$100M
$46,000 0.08% of portfolio
40,000
Q1 2025 Added 14.29%
$117M
$46,000 0.08% of portfolio
17,000
Q4 2024 New
$164M
$48,000 0.08% of portfolio
75,000
Q1 2025 Added 114.29%
$41.1M
$38,000 0.07% of portfolio
35,000
Q4 2024 New
$113M
$38,000 0.07% of portfolio
12,000
Q1 2025 Added 20.0%
$39.2M
$28,000 0.05% of portfolio
35,000
Q4 2024 New
$20.4M
$30,000 0.05% of portfolio
97,000
Q1 2025 Added 38.57%
$7.22M
$11,000 0.02% of portfolio
45,000
Q4 2024 New
$13.6M
$12,000 0.02% of portfolio
25,000
Q4 2024 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 2.59%
Acelyrin Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Upstream Bio Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Perspective Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Tenax Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 1.82%
Corbus Pharmaceuticals Hldgs
-
$0 0.0% of portfolio
-
Q1 2025 Added 4.06%
Instil Bio Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 38.33%
Edesa Biotech Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Kiora Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 7.46%

Summary

  • Portfolio
  • No. of Stocks 49
  • Current Value $58 Million
  • Prior Value $48.4 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 10 stocks
  • Additional Purchases 17 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email